Physician profile
Bruce Halbridge
NPI 1730268053
$407.82
in general payments reported to CMS, 2019-2025
12 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27.51 · 2021: $36.11 · 2022: $106 · 2023: $40.70 · 2024: $54.90 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $67.26 | 2024-2025 | Invega Sustenna, Invega Trinza |
| Roche Diagnostics Corporation | $51.12 | 2020-2021 | |
| Aspira Women'S Health INC | $51.06 | 2022 | |
| Glaxosmithkline, LLC. | $38.13 | 2021-2024 | Rotarix, Bexsero |
| Cranial Technologies, INC | $33.24 | 2022-2023 | Doc Band |
| Dexcom, INC. | $32.41 | 2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $27.23 | 2025 | Veozah |
| Exact Sciences Corporation | $25.73 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $25.16 | 2023 | Vaxelis, Gardasil 9, Proquad |
| Organon LLC | $21.90 | 2022 | |
| Lilly USA, LLC | $18.81 | 2025 | Zepbound, Mounjaro |
| Evofem Biosciences, INC. | $15.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Halbridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.